Literature DB >> 17039414

Auto-antibodies against proteins of spinal cord cells in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS).

Irena Niebroj-Dobosz1, Dorota Dziewulska, Piotr Janik.   

Abstract

Aetiology and pathogenesis of amyotrophic lateral sclerosis (ALS) is still a mystery. Among several hypotheses autoimmune mechanisms are also taken into account. We report here our investigations of auto-antibodies against proteins of spinal cord cells in the cerebrospinal fluid (CSF) and serum of ALS patients. The results were correlated with the severity of disease course. The subjects were 57 ALS patients (29 severe, 28 mild) and 10 normal controls. The major finding in CSF was the presence of antibodies against a 70 kD protein in the majority of ALS patients. This protein was identified as neurofilament 68. The second protein of high reactivity and frequency of appearance was a 82 kD protein, which was identified as a-actinin. Less reactive and less frequent were antibodies directed against 55 kD and 40 kD proteins. They were immunologically defined to be related to desmin and actin, resp. The difference between the reactivity of anti-neurofilament and anti-desmin related protein in the severe and mild ALS groups was significant. More frequent were the anti-neurofilament antibodies in the severe ALS cases as compared to the milder ones. In normal CSF, antibodies directed against 55 kD, 70 kD and 82 kD proteins were present in traces and appeared in 5%, 20% and 10% of cases, respectively. In the serum of 30% of severe ALS patients traces of antibodies against 70 kD protein were detected. The morphological studies in the presence of CSF of ALS patients revealed pronounced immunoreactivity of spinal cord neurons, mainly within anterior horns. The significance of the presence of auto-antibodies in CSF of ALS patients against cellular proteins of the spinal cord is hard to define. It is conceivable that they appear as a secondary immunological consequence of neuronal death. It is also possible that they may accelerate the course of neuronal degeneration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17039414

Source DB:  PubMed          Journal:  Folia Neuropathol        ISSN: 1509-572X            Impact factor:   2.038


  13 in total

Review 1.  Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis.

Authors:  Weihua Zhao; David R Beers; Stanley H Appel
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-25       Impact factor: 4.147

2.  Proteomic analysis of cerebrospinal fluid in pneumococcal meningitis reveals potential biomarkers associated with survival.

Authors:  Upali R Goonetilleke; Matthew Scarborough; Stephen A Ward; Stephen B Gordon
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

3.  Immunological aspects in amyotrophic lateral sclerosis.

Authors:  Maria Carolina O Rodrigues; Júlio C Voltarelli; Paul R Sanberg; Cesario V Borlongan; Svitlana Garbuzova-Davis
Journal:  Transl Stroke Res       Date:  2012-05-03       Impact factor: 6.829

Review 4.  ER stress and unfolded protein response in amyotrophic lateral sclerosis.

Authors:  Kohsuke Kanekura; Hiroaki Suzuki; Sadakazu Aiso; Masaaki Matsuoka
Journal:  Mol Neurobiol       Date:  2009-01-30       Impact factor: 5.590

5.  Development of ALS-like disease in SOD-1 mice deficient of B lymphocytes.

Authors:  Shulamit Naor; Zohar Keren; Tomer Bronshtein; Efrat Goren; Marcelle Machluf; Doron Melamed
Journal:  J Neurol       Date:  2009-03-12       Impact factor: 4.849

6.  Autoimmunity in amyotrophic lateral sclerosis: past and present.

Authors:  Mario Rafael Pagani; Laura Elisabeth Gonzalez; Osvaldo Daniel Uchitel
Journal:  Neurol Res Int       Date:  2011-08-01

7.  Increased intrathecal high-avidity anti-tau antibodies in patients with multiple sclerosis.

Authors:  Lenka Fialová; Ales Bartos; Jana Svarcová; Ivan Malbohan
Journal:  PLoS One       Date:  2011-11-29       Impact factor: 3.240

8.  Highly immunoreactive IgG antibodies directed against a set of twenty human proteins in the sera of patients with amyotrophic lateral sclerosis identified by protein array.

Authors:  Caroline May; Eckhard Nordhoff; Swaantje Casjens; Michael Turewicz; Martin Eisenacher; Ralf Gold; Thomas Brüning; Beate Pesch; Christian Stephan; Dirk Woitalla; Botond Penke; Tamás Janáky; Dezső Virók; László Siklós; Jozsef I Engelhardt; Helmut E Meyer
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

Review 9.  Autoimmune Aspects of Neurodegenerative and Psychiatric Diseases: A Template for Innovative Therapy.

Authors:  Peter de Haan; Hans C Klein; Bert A 't Hart
Journal:  Front Psychiatry       Date:  2017-04-04       Impact factor: 4.157

10.  Postulated vasoactive neuropeptide immunopathology affecting the blood-brain/blood-spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment?

Authors:  Donald R Staines; Ekua W Brenu; Sonya Marshall-Gradisnik
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.